Home › Macular Degeneration › Colorado
Macular Degeneration clinical trials in Colorado
7 studies for Macular Degeneration are looking for participants at sites in Colorado.
Cities in Colorado
A Study in Adults With Geographic Atrophy
- Retina Specialists of Colorado, Aurora
RecruitingPhase 2
Ages 60 and older · All sexes · Updated Sep 21, 2026 · NCT07606365A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- University of Colorado, Aurora
- Retina Consultants of Southern Colorado, Colorado Springs
- Retina Specialists of Colorado - Denver, Denver
- and 3 more
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Sep 18, 2026 · NCT06541704Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Retina Consultants of Southern Colorado, Colorado Springs
RecruitingPhase 2
Ages 55 and older · All sexes · Updated Sep 10, 2026 · NCT066594454D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
- Colorado Retina Associates, Lakewood
RecruitingPhase 1/2
Ages 50 and older · All sexes · Updated Aug 21, 2026 · NCT05197270A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
- Retina Consultants of Southern Colorado, Colorado Springs
- RSC Research LLC, Denver
- Retina Consultants of Southern Colorado, Pueblo
RecruitingPhase 2/3
Ages 50 and older · All sexes · Updated Aug 6, 2026 · NCT07496567Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
- Colorado Retina Associates, Lakewood
RecruitingPhase 1
Ages 50 and older · All sexes · Updated Aug 5, 2026 · NCT07230834Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- Retina Consultants of Southern Colorado P.C., Colorado Springs
- Southwest Retina Consultants, Durango
RecruitingPhase 3
Ages 50 and older · All sexes · Updated Apr 16, 2026 · NCT07064759From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.